Valuation: RushNet, Inc.

Market Cap 12.26M 10.9M 10.17M 9.27M 17.48M 1.18B 17.65M 123M 47.69M 603M 46.05M 45.05M 1.93B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 16.16M 15.09M 13.75M 25.94M 1.75B 26.18M 183M 70.75M 894M 68.31M 66.82M 2.87B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+9,900.00%
Current month+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 2024-03-03
Chief Operating Officer 45 2021-08-01
Director TitleAgeSince
Chairman - 2024-03-03
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00%+9,900.00%-.--% 8.77K
+1.52%-0.49%+4.77%+56.74% 662B
+0.76%-2.97%-2.22%+61.56% 77.11B
-0.02%+3.30%+9.22%+156.20% 67.29B
-3.05%+1.31%+88.02%+1,074.59% 66.55B
+1.83%-0.97%-24.60%-6.48% 45.17B
+2.28%+3.59%-2.36%+78.11% 44.93B
+2.09%+4.86%+16.08%+34.64% 31.59B
+1.25%+0.86%+38.42%+58.54% 25.91B
+3.04%-0.56%-63.41%-59.56% 23.59B
Average +0.97%-0.92%+996.39%+145.43% 104.42B
Weighted average by Cap. +1.16%-1.39%+7.91%+123.31%

Financials

2020 2021
Net sales 4.39M 3.9M 3.64M 3.32M 6.26M 422M 6.31M 44.04M 17.06M 216M 16.47M 16.12M 692M 5.9M 5.24M 4.89M 4.46M 8.41M 567M 8.48M 59.18M 22.93M 290M 22.14M 21.66M 930M
Net income 991K 880K 822K 749K 1.41M 95.24M 1.43M 9.94M 3.85M 48.69M 3.72M 3.64M 156M 164K 145K 136K 124K 233K 15.72M 235K 1.64M 636K 8.04M 614K 601K 25.8M
Net Debt 5.87M 5.22M 4.87M 4.44M 8.37M 564M 8.45M 58.91M 22.83M 288M 22.04M 21.56M 926M 5.93M 5.27M 4.92M 4.48M 8.45M 570M 8.53M 59.5M 23.06M 291M 22.26M 21.78M 935M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
26-10-02 US$0.000001 -.--% 2,000,001
26-10-01 US$0.000001 -.--% 1,600,500
26-09-29 US$0.000001 -.--% 20,000
26-09-28 US$0.000001 -.--% 20,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock